Cardiol Therapeutics Inc. (CRDL)

Nasdaq Biotechnology Diagnostics SIC: 2836
D
Pipeline Grade

Drug Pipeline (0 Assets)

No drugs indexed yet. Pipeline data is populated from ClinicalTrials.gov and openFDA.

Upcoming Catalysts

No upcoming catalysts detected for this company.

Active Clinical Trials (1)

NCT #TitlePhaseStatusEnrollment
NCT06708299 CardiolRx in Recurrent Pericarditis (MAVERIC Phase-3) PHASE3 Recruiting 110

Source: ClinicalTrials.gov. Trial status last updated by sponsor — may not reflect current state.

More Analysis

AI Stock Score

SEC EDGAR fundamental analysis with Claude AI & ChatGPT ratings for CRDL.

SEC EDGAR Filings

All SEC filings for Cardiol Therapeutics Inc. on EDGAR.

Full Calendar

View all upcoming FDA catalysts across all biotech companies.